206 related articles for article (PubMed ID: 3047432)
1. Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses.
Murphy BR; Olmsted RA; Collins PL; Chanock RM; Prince GA
J Virol; 1988 Oct; 62(10):3907-10. PubMed ID: 3047432
[TBL] [Abstract][Full Text] [Related]
2. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.
Connors M; Collins PL; Firestone CY; Sotnikov AV; Waitze A; Davis AR; Hung PP; Chanock RM; Murphy BR
Vaccine; 1992; 10(7):475-84. PubMed ID: 1609551
[TBL] [Abstract][Full Text] [Related]
3. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.
Murphy BR; Sotnikov A; Paradiso PR; Hildreth SW; Jenson AB; Baggs RB; Lawrence L; Zubak JJ; Chanock RM; Beeler JA
Vaccine; 1989 Dec; 7(6):533-40. PubMed ID: 2692334
[TBL] [Abstract][Full Text] [Related]
4. Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV).
Murphy BR; Prince GA; Collins PL; Hildreth SW; Paradiso PR
Vaccine; 1991 Mar; 9(3):185-9. PubMed ID: 2042390
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.
Murphy BR; Prince GA; Walsh EE; Kim HW; Parrott RH; Hemming VG; Rodriguez WJ; Chanock RM
J Clin Microbiol; 1986 Aug; 24(2):197-202. PubMed ID: 3755730
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants.
Murphy BR; Collins PL; Lawrence L; Zubak J; Chanock RM; Prince GA
J Gen Virol; 1989 Aug; 70 ( Pt 8)():2185-90. PubMed ID: 2671259
[TBL] [Abstract][Full Text] [Related]
7. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.
Johnson PR; Olmsted RA; Prince GA; Murphy BR; Alling DW; Walsh EE; Collins PL
J Virol; 1987 Oct; 61(10):3163-6. PubMed ID: 3305988
[TBL] [Abstract][Full Text] [Related]
8. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection.
Murphy BR; Alling DW; Snyder MH; Walsh EE; Prince GA; Chanock RM; Hemming VG; Rodriguez WJ; Kim HW; Graham BS
J Clin Microbiol; 1986 Nov; 24(5):894-8. PubMed ID: 3771779
[TBL] [Abstract][Full Text] [Related]
9. Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus.
Olmsted RA; Buller RM; Collins PL; London WT; Beeler JA; Prince GA; Chanock RM; Murphy BR
Vaccine; 1988 Dec; 6(6):519-24. PubMed ID: 3072795
[TBL] [Abstract][Full Text] [Related]
10. Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.
Elango N; Prince GA; Murphy BR; Venkatesan S; Chanock RM; Moss B
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1906-10. PubMed ID: 3513191
[TBL] [Abstract][Full Text] [Related]
11. Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.
Connors M; Kulkarni AB; Collins PL; Firestone CY; Holmes KL; Morse HC; Murphy BR
J Virol; 1992 Feb; 66(2):1277-81. PubMed ID: 1731105
[TBL] [Abstract][Full Text] [Related]
12. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats.
Prince GA; Horswood RL; Chanock RM
J Virol; 1985 Sep; 55(3):517-20. PubMed ID: 4020957
[TBL] [Abstract][Full Text] [Related]
13. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.
Olmsted RA; Elango N; Prince GA; Murphy BR; Johnson PR; Moss B; Chanock RM; Collins PL
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7462-6. PubMed ID: 3532115
[TBL] [Abstract][Full Text] [Related]
14. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.
Murphy BR; Walsh EE
J Clin Microbiol; 1988 Aug; 26(8):1595-7. PubMed ID: 2459154
[TBL] [Abstract][Full Text] [Related]
15. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
[TBL] [Abstract][Full Text] [Related]
17.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
18. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection.
Walsh EE; Hall CB; Briselli M; Brandriss MW; Schlesinger JJ
J Infect Dis; 1987 Jun; 155(6):1198-204. PubMed ID: 3553346
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee.
Hsu KH; Lubeck MD; Davis AR; Bhat RA; Selling BH; Bhat BM; Mizutani S; Murphy BR; Collins PL; Chanock RM
J Infect Dis; 1992 Oct; 166(4):769-75. PubMed ID: 1527411
[TBL] [Abstract][Full Text] [Related]
20. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.
Murphy BR; Graham BS; Prince GA; Walsh EE; Chanock RM; Karzon DT; Wright PF
J Clin Microbiol; 1986 Jun; 23(6):1009-14. PubMed ID: 3754878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
